Adaptive Biotechnologies ADPT EPS (Diluted)
EPS (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Adaptive Biotechnologies in its filing.
Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.
The official record: Adaptive Biotechnologies’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Adaptive Biotechnologies's eps (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Adaptive Biotechnologies's EPS (diluted)?
- Adaptive Biotechnologies (ADPT) reported EPS (diluted) of -$0.13 in Q1 2026.
- How has Adaptive Biotechnologies's EPS (diluted) changed year-over-year?
- Adaptive Biotechnologies's EPS (diluted) increased by 35.0% year-over-year, from -$0.20 to -$0.13.
- What is the long-term trend for Adaptive Biotechnologies's EPS (diluted)?
- Over 4 years (2021 to 2025), Adaptive Biotechnologies's EPS (diluted) has grown at a -27.9% compound annual growth rate (CAGR), from -$1.48 to -$0.40.
- What does EPS (diluted) mean?
- Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.